Curaleaf’s vaporizer receives medical device designation in the European Union
5 Articles
5 Articles
Green Thumb, Trulieve On The Rise In Q1, Curaleaf And Verano Post Declines - Shanken News Daily
Across the U.S., the cannabis industry is facing headwinds, with leading multistate operators like Curaleaf, Trulieve, Green Thumb, and Verano seeing declining revenue or gains in the low single digits in the first quarter of this year. In recent months, … Continue reading → The post Green Thumb, Trulieve On The Rise In Q1, Curaleaf And Verano Post Declines appeared first on Shanken News Daily.
Organigram And Curaleaf Leadership Talk Latest Earnings
Shadd Dales and Anthony Varrell sit down with two of the biggest names in the cannabis industry: Beena Goldenberg, CEO of Organigram (NASDAQ: OGI), and Boris Jordan, Executive Chairman of Curaleaf (OTCQX: CURLF). Beena breaks down what’s behind Organigram’s record-setting quarter of revenue hitting $65.6 million, fueled by the Motif Labs acquisition and strong growth overseas. Boris Jordan unpacks Curaleaf’s Q1 performance — $310 million in reve…


Curaleaf’s vaporizer receives medical device designation in the European Union
Multinational cannabis operator Curaleaf Holdings Inc (TSE: CURA) (OTCMKTS: CURLF) now has the first-ever liquid extract vaporizer certified for prescription to medical cannabis patients in the European Union. It was created through a collaboration with the TILT Holdings Inc (CBOE CA: TILT) (OTCMKTS: TLLTF) (FRA: 0T01) subsidiary Jupiter Research, LLC. Based in Phoenix, Arizona, Jupiter's sole focus is vaporizer technology for liquid derivatives…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage